Trials / Terminated
TerminatedNCT00891397
Pregabalin Versus Placebo as an Add on for Complex Regional Pain Syndrome (CPRS) of the Upper Limb Managed by Stellate Ganglion Block (The PREGA Study)
Pregabalin vs. Placebo as an Add on for Complex Regional Pain Syndrome of the Upper Limb Managed by Stellate Ganglion Block
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- McMaster University · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy of pregabalin in patients with complex regional pain syndrome Type I and to determine whether it provides clinically significant pain relief and whether it improves functioning of the upper limb.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | Dose of 150mg/day divided in two doses. Increased to 300mg/day then to 600mg/day, always divided in two doses for the day. |
| OTHER | Placebo | Sugar pill |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2010-01-01
- Completion
- 2010-10-01
- First posted
- 2009-05-01
- Last updated
- 2015-04-08
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00891397. Inclusion in this directory is not an endorsement.